financetom
Business
financetom
/
Business
/
GRAINGER ANNOUNCES AGREEMENT TO DIVEST CROMWELL
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GRAINGER ANNOUNCES AGREEMENT TO DIVEST CROMWELL
Oct 17, 2025 3:10 AM

Company plans to focus its portfolio on North America and Japan

CHICAGO, Oct. 17, 2025 /PRNewswire/ -- Grainger , a leading broad line supplier of maintenance, repair and operating (MRO) products serving businesses and institutions, today announced it has entered into a definitive agreement to sell its U.K.-based Cromwell business to AURELIUS, a global private equity investor, distinguished and widely recognized for its operational approach. In September, Grainger also announced the proposed closure of its Zoro U.K. business, subject to the outcome of required legal, regulatory and employment consultation processes in the United Kingdom.

"Over the past decade we've made a concerted effort to focus our portfolio on the geographies where we can deliver the greatest long-term impact. With this, we've altered our assumptions about our future potential in this region," said D.G. Macpherson, Chairman and CEO, Grainger. "We remain committed to creating value for our customers and driving profitable growth through our High-Touch Solutions model in North America and our Endless Assortment businesses in the United States and Japan." 

To account for this event, Grainger will record a one-time, non-cash after-tax loss related to the planned exit of the U.K. market in the range of $190 million to $205 million, the vast majority of which will be recorded in the third quarter of 2025. The transaction is subject to the standard regulatory approvals. This deal is expected to close in the coming months.

About Grainger

W.W. Grainger, Inc. ( GWW ), is a leading broad line distributor with operations primarily in North America, Japan and the United Kingdom. At Grainger, We Keep the World Working® by serving more than 4.5 million customers worldwide with maintenance, repair and operating (MRO) products and value-added solutions delivered through innovative technology and deep customer expertise. Known for its commitment to service and purpose-driven culture, the Company reported 2024 revenue of $17.2 billion. For more information, visit www.grainger.com.

View original content:https://www.prnewswire.com/news-releases/grainger-announces-agreement-to-divest-cromwell-302586884.html

SOURCE W.W. Grainger, Inc. ( GWW )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Russia's Volgograd oil refinery halts operations after Ukrainian drone attack, sources say
Russia's Volgograd oil refinery halts operations after Ukrainian drone attack, sources say
Nov 6, 2025
LONDON, Nov 6 (Reuters) - Russian oil major Lukoil's Volgograd refinery has halted operations after it was struck by Ukrainian drones, three sources familiar with the matter said on Thursday. They said that the primary processing unit, CDU-5, with a daily capacity of 9,100 metric tons, or 66,700 barrels per day - a fifth of the plant's total capability -...
BRIEF-Bombardier CEO says leaving door open to incremental M&A for services, defense business - conf. call
BRIEF-Bombardier CEO says leaving door open to incremental M&A for services, defense business - conf. call
Nov 6, 2025
Nov 6 (Reuters) - Bombardier Inc ( BDRPF ): * BOMBARDIER CEO SAYS LEAVING THE DOOR OPEN TO INCREMENTAL M&A FOR SERVICES AND DEFENSE BUSINESS - CONF. CALL * BOMBARDIER CFO SAYS SUPPLY CHAIN HAS NORMALIZED WITH EXCEPTION OF ENGINES * BOMBARDIER CEO SAYS CO ASSESSING WHETHER TO RAISE JET PRODUCTION Further company coverage: ...
Medical Facilities Reports Lower Q3 Income
Medical Facilities Reports Lower Q3 Income
Nov 6, 2025
08:49 AM EST, 11/06/2025 (MT Newswires) -- Medical Facilities ( MFCSF ) reported Thursday a 7.6% year-on-year decline in net income for the third quarter. The company booked net income from continuing operations of US$12.9 million, or $0.23 per diluted share, down from $14.0 million, or $0.23 per diluted share. Revenue and other income slipped 7% to $82.6 million while...
Eli Lilly's Eloralintide Shows Up to 20.1% Weight Loss in Phase 2 Trial Patients
Eli Lilly's Eloralintide Shows Up to 20.1% Weight Loss in Phase 2 Trial Patients
Nov 6, 2025
08:50 AM EST, 11/06/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Thursday its eloralintide, an investigational once-weekly, selective amylin receptor agonist, demonstrated superior mean weight reductions from 9.5% to 20.1% in a phase 2 trial. The trial featured 263 adults with obesity or who are overweight with at least one obesity-related comorbidity and without type 2 diabetes, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved